Replies to post #31387 on Biotech Values

[DewDiligence]

Re: IDIX

Hi, FL. I did not read anything into the non-mention of IDIX in NVS’ 2Q06 report because the news items re Telbivudine and NM283 were mentioned in NVS’ 1Q06 report (#msg-10793452). Nothing new from a regulatory or licensing standpoint happened during Q2. Regards, Dew

[rkrw]

nvs listed a 2006 eu/row filing for sebivo and = or >2009 filing for 283.